A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite ™ in Subjects With Scabies

Condition:   Scabies Intervention:   Drug: Permethrin Cream 5% Sponsors:   bioRASI, LLC;   Saptalis Pharmaceuticals Completed

Source: ClinicalTrials.gov - June 4, 2019 Category: Research Source Type: clinical trials